MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
-$141,591K
Income tax expense
$40,742K
Income before income
tax expense
-$100,849K
Collaborative Agreements
$71,131K
Product
$122,665K
Royalty
$257,971K
Interest expense
$4,911K
Inducement expense related
to convertible...
$1,369K
Operating income
-$92,891K
Total revenues
$451,767K
Total operating
expenses
$544,658K
Acquired in-process
research and development...
$332,937K
Impairment of intangible
asset
$12,175K
Selling, general and
administrative
$77,028K
Research and development
$20,373K
Amortization of intangibles
$23,376K
Cost of sales
$78,770K
Back
Back
Income Statement
source: myfinsight.com
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)